Screen Rant on MSN
10 DC Universe characters confirmed to debut in 2026 that we can't wait for, ranked
The DC Universe is getting bigger in 2026, with multiple projects introducing exciting characters to the franchise, and these ...
From The Dark Knight, to Parasite, to Mulholland Drive, this is Collider's ranking of the 100 greatest movies of the 21st ...
Looking for a good reason to take your electrically assisted riding off-road? The Grizl:ONfly CF Daily can handle all terrains ...
James Cameron responded to Amy Poehler's 2013 quip about his past marriage to Kathryn Bigelow and says the Golden Globes joke was 'ignorant' ...
Get your fill of an unorthodox Christmas story, an eye-watering comedy, plus bold action and sci-fi, all in one place.
George Clooney, now 63, steps away from on-screen romance, citing age and changing priorities after a talk with Amal Clooney.
The Milwaukee area’s newest concert venue opens its doors this weekend, and a project over three years in the making is coming to fruition. Get ready to say hello to The Argo. Friday night featured a ...
Cryptomining firm Argo Blockchain is set to delist from the UK’s London Stock Exchange amid a majority takeover. The UK company this week announced that, as part of a recapitalization and ...
The base terminal and first few gondola towers of the Mighty Argo Cable Car are worked on Friday, Sept. 26, 2025 at Argo Station in Idaho Springs, Colorado. The Mighty Argo Cable Car gondola, Miners ...
Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...
Novartis has returned to Argo Biopharmaceutical with $160 million in upfront cash to explore various cardiovascular meds in the Chinese biotech’s siRNA pipeline. The latest deal will allow Novartis to ...
Argo and Novartis expand collaboration, focusing on cardiovascular assets, including siRNA therapeutics for severe hypertriglyceridemia and mixed dyslipidemia. Novartis gains licensing rights and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results